Zimmer Biomet’s (ZBH) “Market Outperform” Rating Reaffirmed at JMP Securities
JMP Securities restated their market outperform rating on shares of Zimmer Biomet (NYSE:ZBH – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $140.00 price target on the medical equipment provider’s stock. ZBH has been the topic of several other research reports. Raymond James reduced their price objective […]
JMP Securities restated their market outperform rating on shares of Zimmer Biomet (NYSE:ZBH – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $140.00 price target on the medical equipment provider’s stock. ZBH has been the topic of several other research reports. Raymond James reduced their price objective […]
